Rationale for the use of mineralocorticoid receptor antagonists in heart failure - Ep 117

Insight on the necessary careful selection of patients with HFmrEF/HFpEF to those who are most likely to benefit from mineralocorticoid receptor antagonists. You can read the full manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.2801.

Om Podcasten

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice. ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.